Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort
G. S. Alarcón, M. F. Ugarte-Gil, G. Pons-Estel, L. M. Vilá, J. D. Reveille, G. McGwin
Dive into the research topics of 'Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort'. Together they form a unique fingerprint.